Biotech startup that develops gene therapeutics for muscle wasting diseases. This includes inclusion body myositis, muscular dystrophies, peripheral nerve damage and more. At Aavogen, we make you stronger!
Looking for a particular AAVogen employee's phone or email?
The AAVogen annual revenue was $5 million in 2026.
Buel Rodgers is the Founder and Chief Executive Officer of AAVogen.
2 people are employed at AAVogen.
AAVogen is based in Rockville, Maryland.
The NAICS codes for AAVogen are [541, 5417, 54, 54171, 541713].
The SIC codes for AAVogen are [87, 873].